Organ-on a Chip Market Size, Share, Innovation, Companies & Trends Analysis Report By Product (Standalone DPI, Integrated DPI), By Application (Government, Internet Service Provider, Enterprises, Education, Others) Based on Region, And Segment Forecasts, 2021 - 2027

  • Report ID: BMRC 1689 | Number of pages: 200 | Published Date: Oct 2021

    Published | Category: Healthcare | Delivery Timeline: 48 hrs

COVID-19
To know the impact of COVID-19 On Organ-on a Chip Market Size, Share, Innovation, Companies & Trends Analysis Report By Product (Standalone DPI, Integrated DPI), By Application (Government, Internet Service Provider, Enterprises, Education, Others) Based on Region, And Segment Forecasts, 2021 - 2027 Market

Request Now
Market Size Forecast Scenarios (Optimistic, Baseline and Pessimistic) 2021-2027

Global Organ-on a Chip Market is valued at USD 22.8 Million in 2020 and expected to reach USD 188.6 Million by 2027 with a CAGR of 35.2% over the forecast period.

Global Organ-on a Chip Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027- Increasing development of human tissue chips for improvement in drug discovery, innovative product launches and advancements in technology and private & public sector initiatives to promote awareness among populations are some of the major factors driving the growth of Global Organ-on a Chip Market.

Scope of Global Organ-on a Chip Market Report:

An organ-on-chip is also known a multi-channel 3D microfluidic cell culture chip. It is a type of artificial organ that mimics mechanics, activities and physiological responses of entire organs and organ systems. The size of the organ-on-chip is about an AA battery and its transparency enables to see the organ’s functionality, behavior, and response at the cellular and molecular levels. It is a micro-scale system used for mimicking the human body environment. The goal for organ-on-a-chip is to develop human tissue models for disease modeling and drug testing. Organ-on-chip uses microfluidics with cells to imitate the physiological and mechanical conditions experienced in the body.

Covid-19 has impacted the growth of the global organ-on-chip market. Organ-on a Chip are a technique and processes used to detect various parts of the human body for diagnostic and treatment purposes within healthcare industry. For example; many groups around the world have been testing existing drugs for efficacy against COVID-19 using cultured cells in a living human body. Thus, human organ chips allowed rapid drug repurposing for COVID-19. During the pandemic, in COVID-19 clinical trials, imitating the human lung airway in vitro identified the SARS-CoV2-inhibiting effects of the antimalarial drug amodiaquine to develop drugs.

Also, number of collaboration announced between the research institutes and pharma companies for the further research for Covid-19. For example; Wyss Institute-led collaboration covering four research labs and hundreds of miles has used the Institute’s organ-on-a-chip (Organ Chip) technology to identify the antimalarial drug amodiaquine as a potent inhibitor of infection with SARS-CoV-2, the virus that causes COVID-19. Hence, the results will help to identify infections and treat these high-risk patients more quickly and save the life.   

 Organ-on a Chip Companies :

Some major key players for Organ-on a Chip market report covers are Organovo Holdings, Inc., Tara Biosystems, Emulate, Inc., Hurel Corporation, Ascendance Biotechnology, Inc., Insphero AG, Mimetas B.V., Nortis Inc., AxoSim Technologies LLC, CN Bio Innovations and others.

Global Organ-on a Chip Market Segmentation:

Global Organ-on a Chip market is segmented based upon type, end-users, applications and region & country level. Based upon type, the Organ-on a Chip market is classified into heart-on-chip, intestine-on-chip, kidney-on-chip, liver-on-chip, lung-on-chip and others. Based upon end-users, the Organ-on a Chip market is classified into pharmaceutical and biotechnology companies, academic and research institutes and other end users. Based upon application, the market is classified into drug discovery, toxicology research and other applications.

By Types:

  • Heart-on-chip
  • Intestine-on-chip
  • Kidney-on-chip
  • Liver-on-chip
  • Lung-on-chip
  • Others

By End-User:

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Other End Users

By Application:

  • Drug Discovery
  • Toxicology Research
  • Other Applications

The regions covered in this global Organ-on a Chip Industry report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of Organ-on a Chip is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.

News: Emulate Launched Organ-on a Chip Collaborations

October 20th, 2016; Emulate announced  a pair of research collaborations with Laboratory Corporation of America Holdings (LabCorp) for advancing its Organ-on a Chip platform technology, designed to model human response to diseases, medicines, chemicals, and foods by integrating micro engineering with living human cells. The companies aimed to recreate the natural physiology of human tissues and organs into preclinical drug evaluation and testing services. The collaboration is designed to integrate Emulate’s technology with the drug development expertise of Covance, which acquired by LabCorp. Further that, Emulate expanded its collaboration with LabCorp in the future to embrace additional Organ-Chips and allow commercialization of the Organ-on a Chip technology.

Increasing Development of Human Tissue Chips for Improvement in Drug Discovery, Innovative Product Launches and Advancements in Technology and Private & Public Sector Initiatives to Promote Awareness among Populations are Some of the Major Factors Driving the Market Growth

Increasing development of human tissue chips for improvement in drug discovery is one of the major factors driving the growth of global Organ-on a Chip market. For instance; the World Health Organization’s (WHO) Research emulate lung-chip in response to the COVID-19 outbreak, which was used to provide preclinical visions into the efficacy of hydroxychloroquine for COVID-19 in 2020. In addition, increasing number of product launches by the players and rising number of supportive initiatives to promote awareness among populations are also fostering the market growth.

For example; Emulate launched its Alveolus Lung-Chip is being used by the U.S. Army to understand how the SARS-CoV-2 virus interacts with lung cells. It is used to observe intracellular interactions and better understand the role of proteins within lung cells on disease processes. And; in October 2020, BioVox started an awareness program for through an initiative to promote the organ-on-chip to improve in vitro research models and reduce animal testing.

However, high development cost of organ-on-chip models and their technical difficulties may hamper the market growth. In spite of that, development of advance technologies and increasing drug repurposing approaches in the Organ-on a Chip industry can offer more opportunities for the further growth of the global Organ-on a Chip market.

North America is Expected to Dominate the Global Organ-on a Chip Industry

North America is expected to dominate the global organ-on-chip market with the highest share due the rising collaboration activities for basic drug research and development, increasing technological advancements and their rapid adoption and availability of new and advanced Organ-on a Chip models in this region. Recently, the collaboration between Emulate and the Ellison Institute is designed to foster translational research and expand the range of academic, commercial, and clinical applications for the company’s Human Emulation System human biology model. The integration of Emulate and the Ellison Institute aimed to work together on the development of specific organ and disease models that leverage the Ellison Institute’s expertise in cancer innovation, with the potential to lead to new Organ-Chip products to commercialize within Emulate’s Human Emulation System.

The Asia Pacific is expected to emerge as the fastest-growing regional market over the forecast period due to the large population, growing prevalence of chronic diseases and the increasing healthcare expenditure in this region.   In addition, a rising number of cell-based clinical trials and investment in R&D activities are expected to fuel the growth of the organ-on-a-chip (OOC) market in the Asia-Pacific region.

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia

Latin America

  • Brazil
  • Mexico

The Middle East and Africa

  • GCC
  • Africa
  • Rest of the Middle East and Africa
Report Analysis Details
Historical data 2015 - 2020
Forecast Period 2021 - 2027
Market Size in 2020: USD USD 22.8 Million 
Base year considered 2020
Forecast Period CAGR %:

 35.2% 

Market Size Expected in 2027: USD 188.6 Million 
Tables, Charts & Figures: 175
Pages 200
Organ-on a Chip Companies Organovo Holdings, Inc., Tara Biosystems, Emulate, Inc., Hurel Corporation, Ascendance Biotechnology, Inc., Insphero AG, Mimetas B.V., Nortis Inc., AxoSim Technologies LLC, CN Bio Innovations and others.
Segments Covered By End User, By Type, By Application
Regional Analysis North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Key Benefits of Global OOC Market Report

  • Global OOC Market report covers in-depth historical and forecast analysis.
  • Global Organ-on a Chip Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Organ-on a Chip Companies, Competitive Analysis, Regional and Country Level.
  • Global Organ-on a Chip Market report helps to identify opportunities in marketplace.
  • Global OOC Market report covers extensive analysis of emerging trends and competitive landscape.


Frequently Asked Questions (FAQ) :
An organ-on-chip is also known a multi-channel 3D microfluidic cell culture chip. It is a type of artificial organ that mimics mechanics, activities and physiological responses of entire organs and organ systems.
Global Organ-on a Chip Market is valued at USD 22.8 Million in 2020 and expected to reach USD 188.6 Million by 2027 with a CAGR of 35.2% over the forecast period.
Organovo Holdings, Inc., Tara Biosystems, Emulate, Inc., Hurel Corporation, Ascendance Biotechnology, Inc., Insphero AG, Mimetas B.V., Nortis Inc., AxoSim Technologies LLC, CN Bio Innovations and others.
Increasing Development of Human Tissue Chips for Improvement in Drug Discovery, Innovative Product Launches and Advancements in Technology and Private & Public Sector Initiatives to Promote Awareness among Populations are Some of the Major Factors Driving the Market Growth
North America is Expected to Dominate the Global Organ-on a Chip Market
The sample report for the Organ-on a Chip Market can be obtained on demand from the website. Also, the 24*7 chat support & direct call services are provided to procure the sample report.



Interested in this report?

Organ-on a Chip Market Recent Innovations & Trends | Industry Size, Share, Growth Analysis (2021-2027)

report cover

Request for Table of Content

Organ-on a Chip Market Size, Share, Innovation, Companies & Trends Analysis Report By Product (Standalone DPI, Integrated DPI), By Application (Government, Internet Service Provider, Enterprises, Education, Others) Based on Region, And Segment Forecasts, 2021 - 2027

Note: For delivery of sample pages you must have a Domain Specific Email ID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc. are not accepted.
Brandessence market research actively tracks, monitors, and analyses key industry trends in real-time via B2B surveys in 60 + countries and territories.

    Pricing


Looking for Regional Reports?